Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"140 - Specific philosophical schools"
dewey-ones:"330 - Economics"
product_txtF_mv:"National Center for Biotechnology Information"
Showing
21
-
38
of
38
Search:
''
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
21
High dose influenza vaccine for adults : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Wells, Charlotte
,
Grobelna, Aleksandra
Published 2019
CADTH
Read Now
22
Effect of oseltamivir (TamifluR) for the prevention and treatment of influenza during an influenza pandemic
by
Mørland, Berit
Published 2005
Norwegian Knowledge Centre for the Health Services
Read Now
23
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
24
Pharmacoeconomic review report: Ixekizumab (Taltz)
Published 2017
CADTH
Read Now
25
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
26
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
27
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2017
CADTH
Read Now
28
Pharmacoeconomic review report: Sarilumab (Kevzara)
Published 2017
CADTH
Read Now
29
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
30
Pharmacoeconomic report: Ofatumumab (Kesimpta) (Novartis Pharmaceuticals Canada Inc.) : indication: multiple sclerosis, relapsing-remitting
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
31
Clinical and economic review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
32
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
33
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2020
CADTH
Read Now
34
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
35
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication: for the treatment of adult patients with active ankylosing spondylitis who have responded i...
Published 2020
CADTH
Read Now
36
Pharmacoeconomic review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication: indicated in addition to standard therapy for reducing disease activity in adult patients...
Published 2020
CADTH
Read Now
37
CADTH Canadian Drug Expert Committee recommendation: Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.) : indication: systemic lupus erythematosus (SLE)
Published 2020
CADTH
Read Now
38
Pharmacoeconomic report: Satralizumab (Enspryng) : (Hoffmann-La Roche Limited) : indication : neuromyelitis optica spectrum disorder
Published 2021
Canadian Agency for Drugs and Technologies in Health
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 140 - Specific philosophical schools
Clear Filter
Classification: 330 - Economics
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
330 - Economics
610 - Medicine & health
21
700 - The arts; fine & decorative arts
10
600 - Technology
2
338 - Production
1
more ...
658 - General management
1
see all ...
less ...
Language
English
38
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
29
CADTH Canadian Drug Expert Committee
13
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
4
Campbell, Kaitryn
2
Grobelna, Aleksandra
2
National Research Council (U.S.) Committee on Capitalizing on Science, Technology, and Innovation: An Assessment of the Small Business Innovation Research Program
2
more ...
Wells, Charlotte
2
Wessner, Charles W.
2
Young, Calvin
2
Mørland, Berit
1
Nasjonalt kunnskapssenter for helsetjenesten
1
National Academies of Sciences, Engineering, and Medicine (U.S.) Committee on Capitalizing on Science, Technology, and Innovation: An Assessment of the Small Business Innovation Research Program--Phase II
1
National Research Council (U.S.) Board on Science, Technology, and Economic Policy
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=2&filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&type=AllFields
Send by Email
×
Loading...